● Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Condition: Locally Advanced / Metastatic Solid Tumors · Sponsor: Crescent Biopharma, Inc.

PhasePhase 1/Phase 2

Planned participants290

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Crescent Clinical Trials · 617-430-5595 · clinicaltrials@crescentbiopharma.com

Always discuss trial participation with your own doctor first.

Locations (25)

Clinical Study Site	Birmingham, Alabama, United States	Recruiting
Clinical Study Site	Los Angeles, California, United States	Recruiting
Clinical Study Site	Denver, Colorado, United States	Recruiting
Clinical Study Site	Orlando, Florida, United States	Recruiting
Clinical Study Site	Sarasota, Florida, United States	Recruiting
Clinical Study Site	Detroit, Michigan, United States	Recruiting
Clinical Study Site	Grand Rapids, Michigan, United States	Recruiting
Clinical Study Site	New York, New York, United States	Recruiting
Clinical Study Site	Columbus, Ohio, United States	Recruiting
Clinical Study Site	Pittsburgh, Pennsylvania, United States	Recruiting
Clinical Study Site	Nashville, Tennessee, United States	Recruiting
Clinical Study Site	Dallas, Texas, United States	Recruiting

+ 13 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07335497